Articles of Import
A Primer on Patent Due Diligence The areas of intellectual property include patents, trademarks, copyright, trade secrets and industrial designs. While all intellectual property must be analysed in any due diligence evaluation, this article will generally outline the mechanics and considerations for conducting a patent due diligence. Click Here To Read Article In It's Entirety
Author: Edgar R. Cataxinos
Authors: Edgar R. Cataxinos and Allen C. Turner
Most of the world’s best-selling pharmaceuticals are enantiomeric compounds. For instance, eight of the world’s top 10 best-selling drugs in 2006 had at least one chiral centre, the hallmark of stereochemical activity. These included Lipitor, Plavix, Nexium, Seretide, Zocor, Norvasc, Prevacid and Effexor.
Click Here To Read Article In It's Entirety
Pharma IP and the US Supreme Court (2006-2008)
Author: William S. Britt
Four recent US Supreme Court cases will affect how patents are procured, licensed and litigated in the United States.
These cases are, in chronological order, eBay v. MercExchange, Genentech v. Medimmune, KSR International v. Teleflex and Quanta Computer, Inc. v LG Electronics (argued on January 16, 2008).
Click Here To Read Article In It's Entirety
Licensors Beware: Your Patents Licensed in the USA May be at Risk
Author: William S. Britt
A recent landmark U.S. Supreme Court case, MedImmune v. Genentech (Jan. 9, 2007) held that MedImmune could contest the validity and infringement of a patent (Cabilly II) under which it was licensed by bringing a Declaratory Judgment (D/J) action even though it was not at risk of being sued because it was continuing to pay royalties due under the license and was, therefore, not in breach. This decision changes established U.S. law.
Click Here To Read Article In It's Entirety
U.S. IP Law - Post KSR
Authors: Daniel J. Morath and William S. Britt
This article examines the current disposition of the U.S. Courts towards patents, with especial attention to pharmaceutical patents and inventions.